XV International World AIDS Conference, 11-16 July 2004, Bangkok
6 November 2004. Related: Conference reports.
World AIDS 15 Bangkok 2004
Women and HIV: research directions
6 November 2004. Related: Conference reports, Women's health.
The X4 files: sampling the science on HIV co-receptors in Bangkok
6 November 2004. Related: Conference reports, Antiretrovirals.
XV International World AIDS Conference, 11-16 July 2004, Bangkok
6 September 2004. Related: Conference reports.
Dollars, commerce, politics and prejudice all present obstacles to scaling up access to treatment in resource poor countries
6 September 2004. Related: Conference reports, Treatment access.
MTCT programmes in South Africa: nevirapine and the minister
6 September 2004. Related: Conference reports, Treatment access, Pregnancy.
Urgency of global access to ARV treatment for IV drug users
6 September 2004. Related: Conference reports, Treatment access, Injecting drug users.
Replace myths with evidence–based policies on IV drug use
6 September 2004. Related: Conference reports, Treatment access, Injecting drug users.
Adding Combivir to single dose nevirapine for reduction of MTCT significantly reduces resistance
6 September 2004. Related: Conference reports, Pregnancy.
Lopinavir/r levels reduced during pregnancy
6 September 2004. Related: Conference reports, Pregnancy.
Another chance for 3TC in patients with M184V mutation?
6 September 2004. Related: Conference reports, Antiretrovirals, Treatment strategies, Drug resistance.
Kaletra monotherapy: small studies and early data
6 September 2004. Related: Conference reports, Antiretrovirals, Treatment strategies.
Lowering dose of d4T can maintain efficacy and reduce side effects
6 September 2004. Related: Conference reports, Antiretrovirals.
Three-year renal safety with tenofovir; cystatin may be a useful marker
6 September 2004. Related: Conference reports, Side effects.
Fluconazole increases nevirapine levels and risk of serious hepatotoxicity
6 September 2004. Related: Conference reports, PK and drug interactions.
Efavirenz interaction with rifampin may not require dose adjustment in patients with low body weight
6 September 2004. Related: Conference reports, PK and drug interactions.
Tipranavir significantly lowers doses of saquinavir, amprenavir and lopinavir/r
6 September 2004. Related: Conference reports, PK and drug interactions.
Responses to hepatitis vaccinations: an optimum window for protection?
6 September 2004. Related: Conference reports, Hepatitis coinfection.
HBV vaccine, CD4 count and increasing response with double-dose
6 September 2004. Related: Conference reports, Coinfections and complications, Hepatitis coinfection.
Response to Hepatitis A (HAV) vaccine determined by CD4 count
6 September 2004. Related: Conference reports, Hepatitis coinfection.
Inventive ways to explain HAART and adherence to children
6 September 2004. Related: Conference reports, Paediatric care.
Isoniazid has early and unexpected benefit in reducing childhood mortality
6 September 2004. Related: Conference reports, Paediatric care.